Form 4 for GH Guardant Health, Inc.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-15 · accession 0001968281-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-17 | 2025-11-15 | GH | Tariq Musa | Dir | M - OptEx | $0.00 | +250 | 7,975 | +3% | $0 |
| D | 2025-11-17 | 2025-11-15 | GH | Tariq Musa | Dir | M - OptEx | $0.00 | -250 | 3,998 | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-15 | M | A | 250 | $0.00 | 7,975 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-11-15 | M | D | 250 | $0.00 | 3,998 | D | $0.00 · — to — | 250 Common Stock | (F1) The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |